Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3ζ protein

Biochemical and Biophysical Research Communications

Volumn 383, Issue 1, 2009, Pages 37-41

  Sadik, Golam ^a   Tanaka, Toshihisa ^a   Kato, Kiyoko ^a   Yanagi, Kentaro ^a   Kudo, Takashi ^a   Takeda, Masatoshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

14 3 3 protein; Alzheimer; Frontotemporal dementia; Phosphorylation; Tau

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; STRATIFIN;

ARTICLE; FLUORESCENCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

14-3-3 PROTEINS; HUMANS; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; SURFACE PLASMON RESONANCE; TAU PROTEINS; TAUOPATHIES;

EID: 64949087565     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.107     Document Type: Article

References (25)

1. Kudo T., Tanii H., and Takeda M. Neurodegenerative dementias involving aberrant protein aggregation. Psychogeriatrics 7 (2007) 114-117
2. Tanaka T., Tomioka M., Sadik G., and Takeda M. 13th Congress of the International Psychogeriatric Association and recent expansion of research into psychogeriatrics. Psychogeriatrics 7 (2007) 1-3
3. Himmler A., Drechsel D., Kirschner M.W., and Martin D.W.J. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 9 (1989) 1381-1388
4. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 (1989) 519-526
5. Johnson G.V., and Stoothoff W. Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117 (2004) 5721-5729
6. Andreadis A. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 1739 (2005) 91-103
7. Goode B.L., Chau M., Denis P.E., and Feinstein S.C. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenerative disease. J. Biol. Chem. 275 (2000) 38182-38189
8. Iqbal K., Alonso A.delC., Chen S., Chohan M.O., El-Akkad E., Gong C.-X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., and Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739 (2005) 198-210
9. Ko L.-W., Rush T., Sahara N., Kersh J.S., Easson C., Deture M., Lin W.-L., Connor Y.D., and Yen S.-H. Assembly of filamentous tau aggregates in human neuronal cells. J. Alz. Dis. 6 (2004) 605-622
10. Kampers T., Friedhoff P., Biernat J., Mandelkow E.-M., and Mandelkow E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett. 399 (1996) 344-349
11. Hasegawa M., Crowther R.A., Jakes R., and Goedert M. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J. Biol. Chem. 272 (1997) 33118-33124
12. King M.E., Ahuja V., Binder L.I., and Kuret J. Ligand-dependent tau filament formation: Implications for Alzheimer's disease progression. Biochemistry 38 (1999) 14851-14859
13. Berg D., Holzman C., and Riess O. 14-3-3 proteins in the nervous system. Nat. Rev. Neurosci. 4 (2003) 752-762
14. Sadik G., Tanaka T., Kato K., Yamamori H., Nessa B.N., Morihara T., and Takeda M. Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J. Neurochem. 108 (2009) 33-43
15. Layfield R., Fergusson J., Aitken A., Lowe J., Landon M., and Mayer R.J. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci. Lett. 209 (1996) 57-60
16. Umahara T., Uchihara T., Tsuchiya K., Nakamura A., Iwamoto T., Ikeda K., and Takasaki M. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol. (Berl) 108 (2004) 279-286
17. Umahara T., Uchihara T., Tsuchiya K., Nakamura A., Ikeda K., Iwamoto T., and Takasaki M. Immunolocalization of 14-3-3 isoforms in brains with Pick body disease. Neurosci. Lett. 371 (2004) 215-219
18. Hashiguchi M., Sobue K., and Paudel H.K. 14-3-3 zeta is an effector of tau protein phosphorylation. J. Biol. Chem. 275 (2000) 25247-25254
19. Hernandez F., Cuadors R., and Avila J. Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers. Neurosci. Lett. 357 (2004) 143-146
20. Bhaskar K., Yen S.H., and Lee G. Disease-related modifications in tau affect the interaction between Fyn and Tau. J. Biol. Chem. 280 (2005) 35119-35125
21. Sluchanko N.N., Seit-Nebi A.S., and Gusev N.B. Effect of phosphorylation on interaction of human tau protein with 14-3-3ζ. Biochem. Biophys. Res. Commun. 379 (2009) 990-994
22. Jeganathan S., von Bergen M., Mandelkow E.-M., and Mandelkow E. The natively character of tau and its aggregation to Alzheimer-like paired helical filament. Biochemistry 47 (2008) 10526-10539
23. Sahara N., Maeda S., Murayama M., Suzuki T., Dohmae N., Yen S.H., and Takashima A. Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur. J. Neurosci. 25 (2007) 3020-3029
24. King M.E., Gamblin T.C., Kuret J., and Binder L.I. Differential assembly of human tau isoforms in the presence of arachidonic acid. J. Neurochem. 74 (2000) 1749-1757
25. Sugimori K., Kobayashi K., Kitamura T., Sudo S., and Koshino Y. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease. Psychiatry Clin. Neurosci. 61 (2007) 159-167